Recently, Dorayshield announced the successful export of 15 tungsten alloy collimators to Australia. This marks another significant breakthrough for the company's medical-grade radiation protection products in the Oceania market, demonstrating the company's international competitiveness and laying a solid foundation for further regional cooperation.
The tungsten alloy collimators exported utilize Dorayshield's proprietary high-density alloy formula, with tungsten as the core element and supplemented by nickel, iron, and other metals to optimize material properties. Authoritative testing has shown that the product's radiation shielding efficiency is 1.7 times higher than that of traditional lead materials at the same thickness. Its radiation resistance is also significantly enhanced, ensuring structural stability even after 10 years of intensive use. This technological breakthrough effectively addresses the long-standing radiation leakage challenges faced by medical radiotherapy, industrial flaw detection, and other fields.
The collimators shipped this time are made of 93W-Ni-Fe alloy, with a density of 17.8 g/cm³, a weight of 0.9 kg per unit, and an inner hole concentricity of ≤0.01 mm. They can compress the 99mTc main beam penumbra to 0.3 mm, meeting the requirements for high-resolution SPECT imaging. After comparing quotes from three European and American suppliers, the customer ultimately chose Dorayshield due to its 7-day proofing and 14-day delivery schedule at the Chinese factory, an 18% discount to the same specifications from European manufacturers, and the inclusion of an ISO Declaration of Conformity and a Material Traceability Report.
This order is the result of Dorayshield's long-term commitment to the medical radiation protection field and its active expansion into overseas markets. In recent years, the company has consistently prioritized "technological innovation + quality control," establishing a dedicated R&D team to optimize its product structure. Specifically, the company's tungsten alloy collimator design balances weight and shielding efficiency to meet the needs of medical applications, ensuring effective protection while enhancing the device's portability and installation adaptability. Furthermore, the company has established an efficient foreign trade service system, providing customized solutions and timely after-sales support tailored to the medical market regulations of various countries and regions. Dorayshield's radiation protection products have already entered the medical markets of numerous countries and regions, earning a strong customer reputation. This entry into the Australian market further expands the company's overseas presence.
For Dorayshield, this export to Australia represents far more than a single order. It not only opens up access to the Oceania medical protection market but also provides a valuable reference for the company to further explore regional needs and launch products more tailored to the local market. In the future, the company will take this cooperation as an opportunity to continue to pay attention to the technological trends and market demands in the field of medical radiology in Australia and around the world, increase R&D investment to optimize the product matrix, and deepen the construction of overseas channels to promote more high-quality tungsten alloy protective products to the international market, contributing "Dorayshield power" to global medical radiation safety and helping the company's foreign trade business achieve higher-quality growth.
